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SNprMidbrain GABAergic neurons regulate multiple aspects of behavior and play important roles in psychiatric
and neurological disease. These neurons constitute several anatomical and functional subpopulations, but
their molecular heterogeneity and developmental regulatory mechanisms are poorly understood.
Here we have studied the involvement of the proneural gene Ascl1 in the development of the midbrain GABAergic
neurons. Analysis of Ascl1mutantmicedemonstratedhighly region-speciﬁc requirements forAscl1 for development
of different GABAergic neuron subpopulations. Ascl1 is dispensable for the development of the ventral-most
midbrain GABAergic neurons associated with dopaminergic nuclei substantia nigra pars reticulata (SNpr) and
ventral tegmental area (VTA) GABAergic neurons. In the ventrolateral midbrain, loss of Ascl1 results in markedly
delayed neurogenesis in the midbrain domains m3–m5.Within this region, Ascl1 has a unique role inm4, where it
also regulates glutamatergic neurogenesis. Our results suggest that them3–m5midbrain neuroepitheliumgives rise
to the GABAergic neuron groups located in themidbrain reticular formation and ventrolateral periaqueductal gray.
In contrast to m3–m5, Ascl1 is absolutely required in the dorsal midbrain domains m1–m2, for generation of the
GABAergic neurons populating the superior and inferior colliculi as well as dorsal periaqueductal gray.
These studies demonstrate different molecular regulatorymechanisms for the distinct midbrain GABAergic neuron
subpopulations. Also, our results have implications on understanding the origins of the variousmidbrain GABAergic
neuron groups in the embryonic neuroepithelium., P.O. Box 56, Viikinkaari 9,
+358 9 19159366.
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GABAergic neurons are the primary inhibitory neurons in the
mature brain. Midbrain GABAergic neurons are important compo-
nents of neuronal circuitries regulating multiple aspects of behavior.
They can be divided into anatomical and functional subpopulations.
The ventrally located GABAergic neurons in the SNpr and VTA are
involved in regulation of the dopaminergic pathways. These neurons
are thought to act as both local interneurons controlling dopaminergic
neuron activity and projection neurons contacting other brain regions
(Laviolette and van der Kooy, 2004; Fields et al., 2007; Tepper and Lee,
2007). As a result, the SNpr and VTA GABAergic neurons are very
important in the regulation of motor activity, sensing reward and
motivation. GABAergic neuron subpopulations located in the medial
midbrain include the deep mesencephalic reticular formation, a
functionally and biochemically incompletely analyzed group of
neurons, and periaqueductal gray, which regulates fear and aggres-
sion. The most dorsal GABAergic neurons are located in the superior
and inferior colliculi and are involved in functions such as the
processing and integration of sensory information.In contrast to their functional diversity, rather little is known about
the molecular and developmental heterogeneity of the GABAergic
neuron subpopulations. In the mouse, both ventro-lateral and dorsal
regions of the embryonic midbrain produce GABAergic neurons at
E10.5–E14.5 (midbrain dorso-ventral domains m1–m5) (Tsunekawa
et al., 2005; Nakatani et al., 2007; Kala et al., 2009). Transcription
factors (TFs) Ascl1, Helt and Gata2 have been shown to bemore or less
selectively required for the development of midbrain GABAergic
neurons. Zinc-ﬁnger transcription factor Gata2 is a post-mitotic
selector gene of the GABAergic neurotransmitter phenotype speciﬁ-
cally in the midbrain (Kala et al., 2009). Tissue-speciﬁc inactivation of
Gata2 in the midbrain-rhombomere 1 (r1) region (Gata2cko) results in
the complete transformation of the midbrain-derived post-mitotic
GABAergic neuron precursors into a glutamatergic fate. In a striking
contrast, r1GABAergic neurons developnormally inGata2cko, although
Gata2 also is expressed in the wild-type r1. Interestingly, despite the
phenotypic transformation during midbrain neurogenesis, the most
ventral GABAergic neurons associatedwith the dopaminergic nuclei in
the mature SN and VTA are still found in the Gata2ckomutants at birth.
This suggests a distinct developmental regulatory mechanisms for the
SNpr and VTA GABAergic neurons (Kala et al., 2009).
Basic helix–loop–helix (bHLH) transcription factor Helt is required
for Gata2 expression in the midbrain, except for the ventrolateral m5
domain (Kala et al., 2009). Consistently, GABAergic neurons are only
produced in the m5 domain of the Helt mutant embryos (Guimera et
64 P. Peltopuro et al. / Developmental Biology 343 (2010) 63–70al., 2006b; Nakatani et al., 2007). In addition to the ventral GABAergic
neurons of SNpr and VTA, some more medial GABAergic neurons of
themidbrain reticular formation also develop in theHeltmutants.Helt
is not expressed in the r1 and, consistently, it is not required for
GABAergic neurogenesis there.
The proneural bHLH transcription factor Ascl1 appears to regulate
midbrain GABAergic neurogenesis together with Helt and Gata2, but
through another pathway (Miyoshi et al., 2004; Kala et al., 2009).
Similar to its role in the ventral forebrain, Ascl1 regulates Delta-Notch
signaling in the developing midbrain (Casarosa et al., 1999). In the
forebrain, there are different requirements for Ascl1 in medial and
lateral ganglionic eminences but although defective, GABAergic
neurogenesis can still take place without Ascl1 (Casarosa et al.,
1999). In contrast, Ascl1 was reported to be essential for the
development of midbrain GABAergic neurons (Miyoshi et al., 2004).
Here we have analyzed the requirement for Ascl1 in development
of distinct midbrain GABAergic neuron subpopulations in more detail.
Our results demonstrate highly region-speciﬁc requirements for Ascl1
in the midbrain GABAergic neurogenesis, further underscoring the
developmental heterogeneity of the midbrain GABAergic neurons.
Our results also have implications for understanding the develop-
mental origins of these cells.Materials and methods
Mice
Wild-type and homozygous Ascl1KO embryos were obtained
from intercrosses of Ascl1 +/- mice (Guillemot et al., 1993). Ascl1KOFig. 1. Expression of Ascl1 correlates with GABAergic neurogenesis in the midbrain and rho
coronal sections from E9.5 to E12.5 wild-type midbrain (A–H) and r1 (I–Q). The borders of
with Nkx2.2 and Nkx6.1 on parallel section (not shown). r1, rhombomere 1; mb, midbrainand Gata2cko mutant mice were genotyped as previously described
(Guillemot et al., 1993; Kala et al., 2009). For staging, the day of
vaginal plug was counted as embryonic day 0.5 (E0.5). All experi-
ments were approved by the Committee of Experimental Animal
Research of the University of Helsinki, Finland.
In situ mRNA hybridization
For in situmRNAhybridization (ISH) on sections embryoswereﬁxed
in 4% paraformaldehyde (PFA) at room temperature for 2–7 days.
Samples were dehydrated and mounted into parafﬁn. 5 µm adjacent
sectionswere cut and collected on separate slides for parallel stainings.
mRNA ISH analyses on parafﬁn sections were performed as described
previously (Wilkinson andGreen, 1990) using 35S-labeled RNAprobes.
Mouse cDNA probes used for ISH analysis were:Gad1 (Gad67), Slc17a6
(Vglut2) (Guimera et al., 2006), Ascl1, Ngn2 (Jukkola et al. 2006),
Nkx2.2 (IMAGE clone 480100), Delta1 (IMAGE p968BO7112D6), Hes5
(Gift from I. Thessleff) and Ngn1 (IMAGE p968GO3104D).
Immunohistochemistry
For BrdU-incorporation analysis, pregnant females were given
intraperitoneal injection of BrdU (3 mg/100 g body weight; GE
Healthcare) 1 h before dissecting the embryos.
For immunohistochemistry embryos were ﬁxed for 2–7 days in 4%
PFA at room temperature, dehydrated and embedded in parafﬁn.
Embryos were sectioned coronally at 5 μm. After deparafﬁnation, the
antigen retrieval was done by heating the sections in 10 mM sodium-
citrate buffer, pH6.0, in amicrowave oven for 12 min. The sectionswerembomere 1. Ascl1 and Gad1 expression was analyzed by in situ hybridization (ISH) on
midbrain domains m2–m5 were deduced from immunohistochemistry (IHC) staining
. Scale bar 100 µm.
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solution (TBS+4%BSA+10%goat serum+0.1%Triton-X). The samples
were incubated in the primary antibody in TBS+ 2% BSA+0.1% Triton-
X 1–3 nights at +4 °C, rinsed in TBT (0.1% Triton-X) and placed in the
secondary antibody in TBS + 2% BSA+0.1% Triton-X for 3 h at RT.
Sectionswere rinsed twice in TBS and stainedwith DAPI, rinsed again in
TBS and mounted in Mowiol.
Antibodies used for immunohistochemistry were: rabbit-anti Sox2
(1:400MilliporeAB5603), guinea pig anti-Heslike (Helt 1:400; gift from
R. Kageyama, Institute for Virus Research, Kyoto University, Japan),
mouse anti-BrdU (1:400,Ge Healtcare RPN20AB) mouse anti-HuC/D
(1:800, Molecular probes A21271), mouse anti-Lim1/2 (1:100, Devel-
opmental Studies Hybridoma Bank (DSHB) 4F2), mouse anti-Nkx2.2
(1:400, DSHB 74.5A5), mouse anti-Nkx6.1 (1:400, DSHB F55A10),
mouse anti-Pax6 (DSHB), rabbit anti-caspase (R&D systems AF835),
mouse anti-Gata2 (1:400, SantaCruz sc-9008), rabbit anti-p57 (1:400,
Neomarkers RB-1637-P0), mouse anti-p27 (1:800, BD Transduction
laboratories 610241), rabbit anti-p27 (1:100, Thermo Scientiﬁc Rb-006-
P0), mouse anti-Pou4f1 (1:400, Santa Cruz sc-8429 Clone nr. 14A6),
rabbit anti-cyclinD1 (1:400, Lab-vision RM-9104-SO), mouse anti-TH
(1:400, ChemiconMAB318). Goat anti-rabbit IgG (1:400, Alexa-488 and
Alexa-568, Invitrogen), goat anti-mouse IgG (1:400, Alexa-488 and
Alexa-568, Invitrogen) were used as secondary antibodies.
Microscopy
Staining on parafﬁn sections were visualized with an Olympus
AX70 microscope with Olympus DP70 camera. Images wereFig. 2. Loss of speciﬁc GABAergic neuron groups in the Ascl1 mutant midbrain at E16.5. (A-I
type (Wt), Ascl1KO and Gata2cko midbrains. The dotted line delineates subpopulations of v
GABAergic neurons derived fromm4 region. VTA and SNpr area was deduced from TH-staini
r1 region. vPAG, ventrolateral periaqueductal gray, MBRf, midbrain reticular formation, SC, su
rhombomere 1. Scale bar 200 µm.processed and assembled with Adobe Photoshop software. Red
pseudo-color images representing the ISH results were produced by
replacing the white signal in the dark-ﬁeld images with red and
overlaying the resulting image with the respective bright ﬁeld
image.Results
Expression of Ascl1 correlates with midbrain GABAergic neurogenesis
First, we studied how Ascl1mRNA expression relates to GABAergic
neurogenesis duringmidbrain and r1 development. We compared the
expression of Ascl1 and glutamic acid decarboxylase 1 (Gad1,
GABAergic neurons) in the mouse midbrain and r1 from E9.5 to
E12.5 by in situ hybridization (ISH). At E9.5 Ascl1 expression was ﬁrst
observed in the ventrolateral midbrain and r1 region of the hindbrain
(Fig. 1A, I). Subsequently, ventral expression of Ascl1 becomes more
intense between domains m5 to m2 and expands throughout the
midbrain neuroepithelium both dorsally and ventrally by E11.5
(Fig. 1B–C). At the same time postmitotic GABAergic neurons start
to express Gad1 in the marginal layer, indicating GABAergic dif-
ferentiation (Fig. 1F–G). At E12.5 both Ascl1 and Gad1 are expressed
strongly in ventrolateral and dorsal midbrain and in the r1 region of
the hindbrain (Fig. 1D, H, L, Q). Thus, although not absolutely speciﬁc
for neuroepithelium undergoing GABAergic neurogenesis (Kim et al.,
2008), strong Ascl1 expression is detected in the midbrain and r1
regions giving rise to GABAergic neurons.), ISH with Gad1, Slc17a6 and Nkx2.2 probes on adjacent coronal sections of E16.5 wild-
entral midbrain GABAergic neurons. Black arrows (B, H) point to the Nkx2.2 positive
ng on adjacent section. (J–L) Gad1 ISH on coronal sections fromWt, Ascl1KO and Gata2cko
perior colliculus; VTA, ventral tegmental area, SNpr, substantia nigra pars reticulata; r1,
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Ascl1 mutants
GABAergic neurogenesis was reported to be completely blocked in
the midbrain of Ascl1mutant embryos (Miyoshi et al., 2004). However,
in that study embryos were analyzed at E11.5, when GABAergic
neurogenesis has only just initiated. We looked at GABAergic neurons
in Ascl1mutants at E16.5–E18.5 (Fig. 2A–B, J–K and data not shown). In
agreement with the study byMiyoshi et al., Gad1 expressing GABAergic
neurons were lost in the Ascl1 mutant dorsal midbrain, including
superior and inferior colliculi as well as dorsal periaqueductal gray
(Fig. 2B). However, GABAergic neurons were still present in the medial
and ventral midbrain. In the ventral periaqueductal gray and midbrain
reticular formation, the number of GABAergic neurons was reduced
compared towild-type (Fig. 2A–B). In contrast,Gad1was expressed at a
level comparable to wild type in Ascl1 deﬁcient VTA and SNpr. Also at
E13.5, GABAergic neuronswere produced in the ventromedialmidbrain
(m3–m5), butnot dorsally (m1–m2; Fig. 3B). Thephenotypeof theAscl1
mutants is clearly different from the Gata2cko mutants, in which no
GABAergic neurons are found at E13.5 and only the GABAergic neurons
associated with the ventral dopaminergic nuclei in VTA and SNpr are
present at E16.5 (Fig. 2C). In summary, our observations of the Ascl1
mutant phenotype indicate that different midbrain GABAergic neuron
subpopulations have variable requirements for Ascl1.
To study the origins of the GABAergic neurons less affected by the
loss of Ascl1, we analyzed Nkx2.2 expression in the Ascl1 mutant
embryos. At E13.5, Nkx2.2 is expressed in the neurons derived from
m2 and m4 in wild-type embryos (Fig. 3E). We detected no Nkx2.2
expression in m2 of the Ascl1 mutants, correlating with the loss of
GABAergic precursors in this domain (Fig. 3F, arrow). In contrast,Fig. 3. Loss of speciﬁc GABAergic neuron groups in the Ascl1 mutant midbrain at E13.5.
(A–F), ISH with Gad1, Slc17a6 (Vglut2) and Nkx2.2 probes on adjacent coronal sections
of E13.5 wild-type (Wt) and Ascl1KO midbrain. Black arrow (F) points to Nkx2.2
negative area in the Ascl1 deﬁcient m2, indicating the loss of GABAergic precursors in
this domain. (G–H), Gad1 expression in the r1 region of E13.5 Wt and Ascl1KO embryos.
Scale bar 200 µm.Nkx2.2 was still expressed in m4 in the Ascl1 mutants. In both wild-
type and Ascl1mutant embryos at E16.5, Nkx2.2was expressed in the
medial part of the midbrain reticular formation as well as the ventral
region of the periaqueductal gray (Fig. 2G–H). Nkx2.2 marks both
GABAergic and glutamatergic neurons derived from m4 (Kala et al.,
2009). However, analyses of Gad1 and Vglut2 expression on adjacent
sections suggested that a major proportion of the Nkx2.2 positive
neurons at least in the midbrain reticular formation are GABAergic
(Fig. 2A, D, G, B, E, H and arrowhead). Thus, our results suggest that
the medial subpopulation of GABAergic neurons in the midbrain
reticular formation is derived from the m4 domain and some of these
neurons are still generated in the Ascl1 mutant embryos.
Development of GABAergic neurons in r1 of Ascl1 mutants
Ascl1 has been shown to be expressed in the hindbrain rhombo-
meres (Pattyn et al., 2004). To gain insight to the possible role of Ascl1 in
the GABAergic neurogenesis in the r1 region, we analysed the ex-
pression of Gad1 in Ascl1 mutant embryos at E13.5 (Fig. 3G–H) and at
E16.5 (Fig. 2J–K) by in situ hybridization. Similar to the wild-type and
Gata2cko embryos, we observed abundant Gad1 expression in the r1
region of the Ascl1 mutant embryos, demonstrating that Ascl1 is not
required for the GABAergic neurogenesis in the r1.
Region-speciﬁc delay in GABAergic neurogenesis in Ascl1 mutants
To understand the mechanisms how Ascl1 regulates GABAergic
neuron development in the different cell populations, we next analyzed
the expression of genes characteristic to proliferative progenitors and
post-mitotic precursors of the GABAergic neurons.
At E11.5, the layer of HuC/D positive post-mitotic neurons was
markedly reduced in the m3–m5 of the Ascl1 mutants (Fig. 4A–B).
Conversely, the thickness of the Sox2 positive progenitor cell layer was
increased, indicating a failure in cell cycle exit and onset of dif-
ferentiation.Helt is a speciﬁcmarker of theGABAergic progenitor cells in
theventricular zone. Consistentwith earlier studies,Helt expressionwas
still observed in the Ascl1 mutants (Fig. 4F, Supplementary Fig. 1B, D).
Notably, the relative amount of Helt positive cells was greatly increased
and only few Helt negative cells could be found in the Ascl1 mutant
ventricular zone domains m3–m5 (Fig. 4J), while in the m1–m2
domains Helt expression was completely unaffected (Supplementary
Fig. 1B, D). Gata2 is a Helt dependent marker of the post-mitotic
GABAergic precursors, which are about to exit the ventricular zone and
differentiate. Markedly fewer Gata2 positive cells could be observed in
the Ascl1 mutant midbrains at this stage (Fig. 4N). In addition to
GABAergic neurons,m4domain also gives rise to glutamatergic neurons
in its ventral part. The post-mitotic precursors of these neurons are
characterized by Pax6 expression (Kala et al., 2009). In the Ascl1
mutants, the amount of m4-derived Pax6 positive precursors was
reduced as compared to the WT at E11.5 (Fig. 4M–N). Thus, the
progenitors of m3–m5 are severely impaired in their ability to give rise
to post-mitotic precursors of bothGABAergic andglutamatergicneurons
at E11.5. Glutamatergic neurogenesis may also be affected in the Ascl1
deﬁcient dorsal midbrain as we observed a slight reduction of Pou4f1-
positive cells in m2–m1 region at E13.5 (Supplementary Fig. 1D).
Interestingly, we observed a partial recovery of neurogenesis in the
Ascl1 mutant midbrain by E13.5. In m3–m5, large amounts of
postmitotic precursors expressing GABAergic neuron markers Lim1
(Fig. 4G–H) or Gata2 (Fig. 4P) were observed. Also Pax6 expressing
glutamatergic neuronprecursorswere generated fromm4(not shown).
Inwild-type, the GABAergic neurogenesis is already diminishing inm3–
m5 at this stage, indicated by the down-regulation of Helt expression
(Fig. 4G). In the Ascl1 mutants, the characteristic salt-and-pepper
expression pattern of Helt was restored in the E13.5 Ascl1 mutants
(Fig. 4L). Helt expression levels appeared to be decreasing, suggesting
that the GABAergic neurogenesis ends at around the same stages in
Fig. 4. Analysis of interneuron progenitor and precursor markers in the midbrain domains m3–m5. (A–D) Sox2 and HuC/D expression analyzed by co-IHC in wild-type (Wt) and
Ascl1KO embryos at E11.5 (A, B) and E13.5 (C, D). Midbrain m3–m5 borders are indicated in white lines. (E–P) Helt and Pou4f1 co-IHC (E–F), Helt (IHC, I–J), Gata2 and Pax6 (co-IHC,
M–N) expression is shown in E11.5 embryos. Note the increased Helt expression levels in the Ascl1 mutant (J) and loss of the characteristic salt-and-pepper expression pattern (I).
E13.5 wild-type (WT) and Ascl1KO embryos were analyzed for Helt and Lim1 (co-IHC, G–H), Helt (IHC, K–L) and Gata2 (IHC, O–P). Scale bar 200 µm.
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the initiation of GABAergic neurogenesis is delayed, but still takes place
in midbrain m3–m5 regions without Ascl1.
Ascl1 regulates separation of neurogenic and neural stem cell fates
in m3–m5
To study the defect in neurogenesis in more detail, we analyzed
expression of genes regulating the fate selection between neural stem/
progenitor cells and differentiating post-mitotic neurons. The lateral
inhibition via Delta-Notch pathway is central for the control of this
process, asNotch ligandDelta expressed in thedifferentiatingneurons is
stimulating Notch receptor and activating its target gene expression in
the adjacent cells. One such Notch target isHes5, which is important for
the maintenance of the neural stem cell identity in the neuronal
progenitors. Delta expression has been shown to be regulated by
proneural genes in several regions of the CNS. Consistently,we observed
rather complete down-regulation of Delta1 expression in the m3–m5
region of Ascl1mutants at E11.5 (Fig. 5A–B). Correlatingwith the down-
regulation of Delta1, also Hes5 expression was abolished in the m3–m5
region (Fig. 5E–F). In contrast to m3–m5, Delta1 and Hes5 were still
expressed in them1–m2regionof theAscl1mutants. This is likely due to
glutamatergic neurogenesis driven by Ngn2/Ngn1. No compensatory
up-regulation of Ngn2 or Ngn1 was observed in the Ascl1 mutants
(Fig. 5I–P, Supplementary Fig. 1E–H). Nevertheless, in the E13.5
embryos we observed restored Delta1 expression in the m5–m3,although in reduced levels (Fig. 5C–D). Simultaneously Hes5 recovered
to wild-type levels in Ascl1mutant midbrain (Fig. 5G–H).
Unique requirements for Ascl1 in m4
In addition to regulating the Delta-Notch pathway, proneural
genes have been shown to affect cell cycle regulation through in-
teraction with cyclin-dependent kinase inhibitors. Therefore, we
analyzed the proliferative cell markers as well as the expression of
cyclin dependent kinase inhibitors p27, p57 and cyclin D1 in the m3–
m5 of wild-type and Ascl1 mutant embryos at E11.5. The amounts of
p27 positive post-mitotic precursors were reduced in the marginal
zone of m3–m5, in contrast to the ventricular zone, where p27
seemed to be up-regulated (Fig. 6C–D). Interestingly, this up-
regulation was clearly more prominent in the m4 when compared
to the adjacent m3 and m5 domains (Fig. 6D, arrowhead). Similarly,
p57 and HuC/D expression was observed closer to the ventricular
surface in the m4 (Fig. 6F, arrowhead). Consistently, cyclinD1 ex-
pression was down-regulated in the m4 domain (Fig. 6G–H,
arrowhead), indicating that in m4 cells are able to exit cell cycle.
Despite the more prominent expression of the postmitotic precursor
markers in m4, cell proliferation was still active also in m4 of the Ascl1
mutants (Fig. 6B). These results suggest that without Ascl1 the neural
progenitors in m3–m5 fail to properly exit the ventricular zone.
Paradoxically however, the progenitors also loose characteristics of
the neural stem cells and precociously activate expression of some of
Fig. 5. Neurogenic and neural stem cell –speciﬁc gene expression. ( A-P) ISH analysis of Delta1, Hes5, Ngn2 and Ngn1 at E11.5 and E13.5 in the wild-type (WT) and Ascl1KO embryos.
Scale bar 200 µm.
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Ascl1 is highly region speciﬁc, and there appears to be distinct
requirements for it even within m3–m5 region.
Discussion
Midbrain GABAergic neurons are involved in functions such as
regulation of mood, movement and nociception and thus comprise
clinically highly important targets. However, their developmental
regulatory mechanisms are largely unknown. Here we show that
various subpopulations of GABAergic neurons in the midbrain and r1
have distinct requirements for Ascl1. GABAergic neurons associated
with the dopaminergic nuclei in the VTA and SN do not require Ascl1.
Also, Ascl1 is dispensable for GABAergic neurogenesis in the r1. In
contrast, loss of Ascl1 results in delayed neurogenesis in the
lateromedial midbrain (m3–m5), and reduced numbers of GABAergic
neurons populating mesencephalic reticular formation and ventral
periaqueductal gray. The dorsal midbrain (m1–m2) has the strictest
requirement for Ascl1, as no GABAergic neurons populating superior
and inferior colliculi as well as dorsal periaqueductal gray are
generated in Ascl1 mutant midbrain.
In an interesting similarity to the Ascl1 mutant mice, GABAergic
neurons of the VTA and SNpr are also unaffected in Helt and Gata2cko
mutants. This suggests that these neurons are very different from the
rest of the midbrain GABAergic neurons. The phenotype of the Gata2cko
mutants is themost clear-cut: despite complete loss of GABAergic gene
expression in the embryonic midbrain at the time of neurogenesis(E11.5–E13.5) and transformation of the neurotransmitter phenotype
of all other midbrain GABAergic neurons, the VTA and SNpr GABAergic
neurons were apparently normal (Kala et al., 2009). This ﬁnding
suggested that these neurons may have their developmental origin
outside themidbrain. This hypothesis proves to be correct, as our recent
fate mapping results show that the VTA and SNpr GABAergic neurons
are derived from the r1 (K.K, J.P., unpublished). Consistent with this, the
GABAergic neurons in r1 do not require Gata2 (Kala et al., 2009), Helt
(Guimera et al., 2006b; Nakatani et al., 2007), or Ascl1 (present study)
for their development. Our ﬁndings in vivo are also in agreement with a
recent study demonstrating that Ascl1 can promote GABAergic
neurogenesis in in vitro cultured neural progenitors derived from the
midbrain but not from the ones derived from the r1 (Jo et al., 2007).
Thus, our results suggest that the VTA and SNpr GABAergic neurons are
spared in the Ascl1mutant midbrain because these neurons are born in
the r1 where Ascl1 is not required for GABAergic neurogenesis.
Unlike in Gata2cko midbrain, GABAergic neurons are still produced
in the m3–m5 domains of the Ascl1 mutants. This is in contrast to a
previous study, which concluded that essentially no GABAergic
neurons are produced in the Ascl1 mutant midbrain (Miyoshi et al.,
2004). A likely explanation is that these authors analyzed only a
relatively early time point of GABAergic neurogenesis in themidbrain.
Our results showed that although post-mitotic GABAergic neuron
precursors were still generated from Ascl1 deﬁcient m3–m5, the
neurogenesis was markedly delayed. This correlated with loss of
Delta1 and Hes5 expression in m3–m5 at E11.5, consistent with the
function of Ascl1 in the ventral forebrain (Casarosa et al., 1999).
Fig. 6. Markers of cell cycle progression and onset of differentiation in the midbrain
domainsm3–m5. co-IHC analysis of Sox2 and BrdU (A–B), p27 and BrdU (C–D), p57 and
HuC/D (E–F), cyclinD1 and HuC/D (G–H) in the wild-type and Ascl1KO embryos at
E11.5. White arrowheads demonstrate ventricular up-regulation of p27, p57 and HuC/
D in the Ascl1KO m4 region. Scale bar 100 µm.
Fig. 7. Ascl1KO phenotype in comparison with Gata2cko. Different subpopulations of
GABAergic neurons in the midbrain have distinct requirements for Ascl1. In the dorsal
midbrain domains m1–m2, Ascl1 function is absolutely required. In domains m3–m5,
loss of Ascl1 results in delayed neurogenesis. Unlike in Gata2cko, there is no evidence of
cell fate transformation in the GABAergic neurons of Ascl1KO. GABAergic neurons
associated with dopaminergic nuclei in VTA, SNpr and r1 do not require Ascl1 function,
similar to the Gata2. Also the glutamatergic neurogenesis in m6 is not affected by the
loss of either Ascl1 or Gata2. IC, inferior colliculus; MBRf, midbrain reticular formation;
LDPAG, dorsolateral periaqueductal gray; SC, superior colliculus; SNpr, substantia nigra
pars reticulata; r1, rhombomere 1; vPAG, ventrolateral periaqueductal gray; VTA,
ventral tegmental area.
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characteristic to the cellular intermediates between the neuroepithe-
lial stem cells and post-mitotic neurons. One of these genes may be
Helt, which is rather ubiquitously expressed in m3–m5 neuroepithe-
lium in the E11.5 Ascl1 mutants compared to the salt-and-pepper
expression pattern observed in the wild-type. Previous studies have
shown that Helt is expressed in the ventricular zone where the
proliferative neural progenitors are located (Miyoshi et al., 2004;
Guimera et al., 2006a) and that the Helt expressing cells likely give
rise to Gata2 positive post-mitotic precursors (Kala et al., 2009).
Whether Helt-positive cells are still active in the cell cycle or
represent an early stage of post-mitotic neural differentiation has
not been conclusively demonstrated. Since the m3–m5 neuroepithe-
lial cells in Ascl1 mutants ubiquitously express Helt yet still are
proliferative, this strongly argues that at least some of the Helt
expressing cells represent proliferative intermediates between neu-
roepithelial stem cells and post-mitotic GABAergic precursors.
Other indicator of an intermediate cell differentiation phenotype
in the Ascl1 mutants is the expanded expression of cell cycle
regulators p27 and p57, which was especially prominent in the m4
domain. The midbrain domain m4 also differs from the surrounding
midbrain neuroepithelium as it gives rise to both GABAergic and
glutamatergic neurons (Kala et al., 2009). Interestingly, unlike other
midbrain regions giving rise to glutamatergic neurons, m4 does not
express proneural genes Ngn1 or Ngn2. Instead, our results indicate
that Ascl1 also promotes glutamatergic neurogenesis in m4.
Taken together, in the Ascl1 mutant midbrain m3–m5 domains,
separation of the neuroepithelium into stem cell -like cells and
differentiating progenitors appears to fail at the start of neurogenesis.
Our results are consistent with suggestions that proneural genes havedual functions: Their oscillatory expression is needed for the
maintenance of the neural progenitors, whereas sustained expression
drives neuronal differentiation (Kageyama et al., 2009). However, later
in development, the defect in Ascl1mutants is overcome as Delta1 and
Hes5 expression was restored and we also observed abundant GABA-
and glutamatergic neurogenesis. Due to the initial delay in the start of
neurogenesis, the m3–m5 derived neurons are born during shorter
time period and thus possibly in reduced numbers. This appears
similar to the function of Ascl1 in the generation of the neurons of the
nucleus of the solitary tract and symphatetic chain (Pattyn et al., 2006).
In contrast to the other regions of the midbrain, there was a strict
requirement for Ascl1 in GABAergic neuron progenitors in the dorsal
midbrain (m1–m2). The loss of GABAergic neurogenesis in m1–m2
correlated with complete loss of GABAergic neurons in the superior
70 P. Peltopuro et al. / Developmental Biology 343 (2010) 63–70and inferior colliculi as well as dorsal periaqueductal gray, demon-
strating that these GABAergic subpopulations are likely completely
derived from the dorsalm1–m2domains. This result is consistentwith
previous studies demonstrating GABAergic neurogenesis in the dorsal
midbrain and analyses of the Helt mutant mice (Tan et al., 2002;
Tsunekawa et al., 2005; Guimera et al., 2006b; Nakatani et al., 2007).
Despite the speciﬁc loss of the dorsal GABAergic neurons, expression
of Delta1 and Hes5 is clearly less affected in the dorsal midbrain (m1–
m2) compared to the ventrolateral midbrain (m5–m3) in the Ascl1
mutants. This is likely due to continued glutamatergic neurogenesis
driven byNgn1 andNgn2 in the dorsalmidbrain. As discussed above, no
GABAergic neurons are produced in the dorsal m1–m2 midbrain
domains even at later stages. This may represent cell-intrinsic
differences between m1–m2 and m3–m5. However, sustained expres-
sion of Helt in the Ascl1 mutants argues against a phenotypic trans-
formationof theventricular zoneprogenitors. Alternatively, theongoing
glutamatergic neurogenesis may further repress GABAergic neurogen-
esis in m1–m2 through lateral inhibition. Consequently, combinatory
effects of Ascl1 inactivation and continued Delta-Notch signaling may
lead to a complete block of GABAergic neurogenesis in m1–m2.
There is no rigorous fate map of how the different regions of the
midbrain neuroepithelium contribute to the various GABAergic neuron
subpopulations. Comparison of the phenotypes of the Ascl1KO and
Gata2cko mutant phenotypes together with persistent Nkx2.2 expres-
sion in postmitotic precursors suggest the following model (Fig. 7): the
most ventral GABAergic neurons of VTA and SNpr are born outside the
midbrain (see discussion above). The GABAergic neurons of the
midbrain reticular formation and ventral periaqueductal gray are
derived from domains m3–m5. Finally, the GABAergic neurons of the
superior colliculi and laterodorsal periaqueductal gray are completely
derived from the domains m1–m2.
Conclusion
In the various subpopulations of midbrain GABAergic neurons, the
requirements for proneural gene Ascl1 function are different during
neurogenesis. Partly, these differences reﬂect distinct developmental
origins of these subgroups of clinically highly important neurons. Our
results also support a dual role of proneural genes in supporting
neural stem cells and promoting neurogenic cell cycle exit.
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